Home >> Signaling Pathways >> Tyrosine Kinase >> Bcr-Abl


Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).

  1. Cat.No. Product Name Information
  2. A8605 1-Naphthyl PP1 Src family kinases inhibitor
  3. A8602 Adaphostin P210bcr/abl tyrosine kinase inhibitor
  4. C5826 AG957 a tyrphostin that targets transforming Bcr-Abl fusion proteins
  5. B1011 Bafetinib (INNO-406) Bcr-Abl/Lyn tyrosine kinase inhibitor
  6. A2149 Bosutinib (SKI-606) Potent Abl/Src kinases
  7. A8722 CHMFL-ABL-053 BCR-ABL inhibitor
  8. A3017 Dasatinib (BMS-354825) Src and BCR-Abl inhibitor
  9. B1404 DCC-2036 (Rebastinib) Bcr-Abl inhibitor
  10. A8603 GNF 2 Bcr-Abl inhibitor
  11. A8604 GNF 5 Bcr-Abl inhibitor

Items 1 to 10 of 21 total

per page
  1. 1
  2. 2
  3. 3

Set Descending Direction